Andrew R Moya, Pooya Tehrany, Kassem Ghayyad, Ramakanth Yakkanti, Andrew Pepper
{"title":"Clinical Recommendations for the Perioperative Management of Biologic Medications for Nonrheumatologic Diseases in Total Joint Arthroplasty.","authors":"Andrew R Moya, Pooya Tehrany, Kassem Ghayyad, Ramakanth Yakkanti, Andrew Pepper","doi":"10.2106/JBJS.RVW.25.00004","DOIUrl":null,"url":null,"abstract":"<p><p>» Managing biologic therapies in nonrheumatologic patients undergoing total joint arthroplasty (TJA) poses unique risks, such as infection, and wound healing issues, yet guidelines are limited.» Some agents may be continued during the perioperative period, while others may need to be temporarily withheld before surgery.» The absence of clear perioperative guidelines for patients on biologics underscores the need for evidence-based protocols to support optimal surgical outcomes.» A deeper understanding of biologic pharmacodynamics in the perioperative period can help manage risks, particularly as the demand for TJAs in biologic-treated patients grows.</p>","PeriodicalId":47098,"journal":{"name":"JBJS Reviews","volume":"13 4","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JBJS Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2106/JBJS.RVW.25.00004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
» Managing biologic therapies in nonrheumatologic patients undergoing total joint arthroplasty (TJA) poses unique risks, such as infection, and wound healing issues, yet guidelines are limited.» Some agents may be continued during the perioperative period, while others may need to be temporarily withheld before surgery.» The absence of clear perioperative guidelines for patients on biologics underscores the need for evidence-based protocols to support optimal surgical outcomes.» A deeper understanding of biologic pharmacodynamics in the perioperative period can help manage risks, particularly as the demand for TJAs in biologic-treated patients grows.
期刊介绍:
JBJS Reviews is an innovative review journal from the publishers of The Journal of Bone & Joint Surgery. This continuously published online journal provides comprehensive, objective, and authoritative review articles written by recognized experts in the field. Edited by Thomas A. Einhorn, MD, and a distinguished Editorial Board, each issue of JBJS Reviews, updates the orthopaedic community on important topics in a concise, time-saving manner, providing expert insights into orthopaedic research and clinical experience. Comprehensive reviews, special features, and integrated CME provide orthopaedic surgeons with valuable perspectives on surgical practice and the latest advances in the field within twelve subspecialty areas: Basic Science, Education & Training, Elbow, Ethics, Foot & Ankle, Hand & Wrist, Hip, Infection, Knee, Oncology, Pediatrics, Pain Management, Rehabilitation, Shoulder, Spine, Sports Medicine, Trauma.